Benzodiazepines confirm method

ToxicologyAlso known as: Benzodiaz Cfm Meth UrN/A

Confirms the presence of benzodiazepines in urine using advanced detection methods.

Normal Range
Consult your provider
N/A
Abnormal Levels
Consult your provider
Specimen Type
Blood

Why This Biomarker Matters

Confirmatory testing verifies benzodiazepine use, medication compliance, and detects unauthorized use in clinical, occupational, or forensic settings with high accuracy.

Overview

This confirmatory urine test detects the presence of benzodiazepines, a class of sedative medications used to treat anxiety, insomnia, and seizures. The 'confirm method' uses advanced laboratory techniques (such as mass spectrometry) to definitively identify benzodiazepines, rather than screening tests that may give false positives. This test is used in clinical settings to verify medication use, monitor compliance with prescribed benzodiazepines, and in forensic or occupational health contexts to detect unauthorized use. It provides a reliable, specific identification of benzodiazepine presence.

Technical Information (LOINC Codes)

Standardized laboratory codes for this biomarker

19286-4Primary
Benzodiazepines confirm method [Identifier] in Urine